Search
for
Sort by
Research 451–480 of 1000+
- Affect of a six months treatment regiment of metformin (MET) on 17-hydroxyprogesterone (17P) responses to GnRH agonist (GnRH Ag) in polycystic ovary syndrome (PCOS)
- Metformin and Amoxicillin/Clavulanate as Co-Administration for the Treatment of Hyperglycemia in Female Rats Caused by Alloxan.
- Metformin induced hair loss in 2 cases
- Pituitary Effects of Metformin in Men With Early‐Onset Androgenic Alopecia
- Does finasteride, as well as metformin, improve insulin resistance in PCOS?
- Therapeutic Potential of Topical Metformin in Diabetic Wound Healing: Preclinical Mechanistic Insights
- Anticancer effects of metformin on neuroendocrine tumor cells in vitro
- COMPARISON OF METFORMIN WITH VITAMIN D SUPPLEMENTATION AND METFORMIN ALONE INTERMS OF REDUCTION IN LEVEL OF HBA1C IN PATIENTS DIAGNOSED WITH DIABETES MELLITUS TYPE II
- Specific interpretation of hair concentrations in 2 fatal metformin intoxication cases
- FINASTERIDE (PLUS ORAL CONTRACEPTIVE PILL) VS METFORMIN IN TREATMENT OF POLYCYSTIC OVARY SYNDROME-RELATED INFERTILITY: A PROSPECTIVE RANDOMIZED TRIAL
- Metabolic complications of glucocorticoids – Prevention by metformin
- Factorial Design-Based Development and Evaluation of Metformin Hydrochloride-Loaded Mucoadhesive Microspheres for Sustained Anti Hyperglycaemic and Anticancer Activity
- Comparative analysis between ethinyl estradiol & cyperoterone acetate with or without metformin therapy in the treatment of polycyctic ovarian syndrome induced hirsutism
- Efficacy and Safety of Vildagliptin and Remogliflozin as Add-on Therapy to Metformin in Patients of Type 2 Diabetes Mellitus
- Consensus on women’s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group
- Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline
- Epidemiology, diagnosis, and management of polycystic ovary syndrome
- Assessment of Cardiovascular Risk and Prevention of Cardiovascular Disease in Women with the Polycystic Ovary Syndrome: A Consensus Statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society
- The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Polycystic Ovary Syndrome
- The pathophysiology of polycystic ovary syndrome
- Role of insulin, insulin‐like growth factor‐1, hyperglycaemic food and milk consumption in the pathogenesis of acne vulgaris
- Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity
- Antiandrogens for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Insulin Sensitizers for the Treatment of Hirsutism: A Systematic Review and Metaanalyses of Randomized Controlled Trials
- Nonalcoholic fatty liver disease and polycystic ovary syndrome
- Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne
- Hyperandrogenism and Polycystic Ovary Syndrome in Women with Type 1 Diabetes Mellitus
- Stimulation of Hair Growth by Small Molecules that Activate Autophagy